
Montelukast (10mg) + Levocetirizine (5mg)
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medical applications
Monlevo Tablet is a prescription medicine that combines the active ingredients Levocetirizine and Montelukast. The Levocetirizine component is a potent histamine receptor antagonist, whereas the Montelukast component is a leukotriene receptor antagonist. This unique combination provides rapid and sustained relief from symptoms of seasonal allergic rhinitis and chronic idiopathic urticaria. Monlevo Tablet effectively alleviates symptoms such as sneezing, runny nose, itchy and watery eyes, and skin rashes. The medication also helps to reduce nasal congestion, itching, and hives. By blocking the action of histamine and leukotrienes, Monlevo Tablet prevents the release of chemical mediators responsible for allergic reactions. The recommended adult dose is one tablet once daily. Monlevo Tablet is contraindicated in patients with hypersensitivity to Levocetirizine or Montelukast, or with known allergy to any of the ingredients. As with any medication, patients should consult their physician before taking Monlevo Tablet, especially if they have a history of kidney or liver disease, or if they are taking other medications.
How to use Monlevo Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Monlevo Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Monlevo Tablet. Please consult your doctor.
High Risk
Monlevo Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Monlevo Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Monlevo Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Monlevo Tablet may be needed. Please consult your doctor. Limited information is available on the use of Monlevo Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Monlevo Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Monlevo Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monlevo Tablet may be needed. Please consult your doctor. Use of Monlevo Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Monlevo Tablet

Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Medical applications
Monlevo Tablet is a prescription medicine that combines the active ingredients Levocetirizine and Montelukast. The Levocetirizine component is a potent histamine receptor antagonist, whereas the Montelukast component is a leukotriene receptor antagonist. This unique combination provides rapid and sustained relief from symptoms of seasonal allergic rhinitis and chronic idiopathic urticaria. Monlevo Tablet effectively alleviates symptoms such as sneezing, runny nose, itchy and watery eyes, and skin rashes. The medication also helps to reduce nasal congestion, itching, and hives. By blocking the action of histamine and leukotrienes, Monlevo Tablet prevents the release of chemical mediators responsible for allergic reactions. The recommended adult dose is one tablet once daily. Monlevo Tablet is contraindicated in patients with hypersensitivity to Levocetirizine or Montelukast, or with known allergy to any of the ingredients. As with any medication, patients should consult their physician before taking Monlevo Tablet, especially if they have a history of kidney or liver disease, or if they are taking other medications.
How to use Monlevo Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Monlevo Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Monlevo Tablet. Please consult your doctor.
High Risk
Monlevo Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Monlevo Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Monlevo Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Monlevo Tablet may be needed. Please consult your doctor. Limited information is available on the use of Monlevo Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Monlevo Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Monlevo Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monlevo Tablet may be needed. Please consult your doctor. Use of Monlevo Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Monlevo Tablet















